Medicine and Dentistry
Kidney Metastasis
95%
Computer Assisted Tomography
56%
Overall Survival
55%
Progression Free Survival
49%
Blood Flow
44%
Interleukin 2
20%
Biological Marker
18%
Prognostic Factor
16%
Clear Cell Renal Cell Carcinoma
16%
Microvessel
16%
Kidney Carcinoma
16%
Iodinated Contrast Medium
16%
Progressive Disease
16%
Reproducibility
16%
Biopsy
16%
Adverse Event
16%
Hazard Ratio
12%
Neoplasm
11%
Angiogenesis
10%
Metastatic Carcinoma
9%
Multivariate Analysis
7%
Functional Imaging
6%
Treatment Response
5%
Angiogenesis Inhibitor
5%
Immunology and Microbiology
Carcinoma Cell
100%
Computer Assisted Tomography
58%
Overall Survival
53%
Progression Free Survival
48%
Blood Flow
25%
Tincture of Iodine
16%
CD34
16%
Immunotherapy
8%
Bevacizumab
6%
Perfusion
5%
Angiogenesis
5%
Angiogenesis Inhibitor
5%
Pharmacology, Toxicology and Pharmaceutical Science
Kidney Metastasis
72%
Overall Survival
52%
Progression Free Survival
49%
Interleukin 2
20%
Biological Marker
18%
Adverse Event
16%
Iodinated Contrast Medium
16%
Kidney Carcinoma
16%
Immunotherapy
9%
Bevacizumab
8%
Angiogenesis Inhibitor
5%